Nebu-Flow develops nebulisers for respiratory drug delivery, utilizing a patented aerosol formation technology for efficient delivery of hard-to-nebulise drugs.

Nebu-Flow

Nebu~Flow is developing next generation of nebulisers to unlock delivery of next generation of inhaled drugs

Ascension Life Fund

SCVC

SIS Ventures

Foresight Williams

Nebu~Flow 

📦It's packing time! 📦 
We are getting ready for our move to a fantastic new location. Stay tuned for more updates... 🏢✨

Glasgow-based medical device firm Nebu~Flow has secured an additional £4.7 million of investment to help accelerate the next generation of inhaled drugs for patients with respiratory conditions. 

#Tech | #News | #Glasgow

Today's The Herald Scotland reports on Nebu~Flow  securing an additional £4.7 million of investment to accelerate the next generation of inhaled drugs for patients with respiratory disorders, which are the main cause of death and disability worldwide.  The company’s nebuliser platform has been developed to provide a number of advantages over existing technologies. Overall, the worldwide inhalable drug market was valued at approximately $33 billion in 2023, with the nebuliser market valued at over $1 billion.  

The funding round was led by SCVC, a leading UK-based venture capital firm that invests in early-stage deep tech spinouts, and was supported by Scottish Enterprise, Foresight WAE Technology, SIS Ventures, Ascension, and Conduit EIS Impact Fund.

I am pleased to announce that Foresight Group has provided follow on investment to Nebu~Flow .

Congratulations to Elijah Nazarzadeh and the rest of the team. I look forward to continue working with you on the next stage of the journey.

I am delighted to announce Nebu~Flow ’s latest investment from a group of brilliant investors, bringing the total investment in our new category of nebulisers, transforming inhalation drug delivery, to above £8.5m. 

Thanks to all our investors with their continued support SCVC, Scottish Enterprise, Foresight Group, WAE, SIS Ventures ,Ascension Life Fund, Conduit Connect

#startup #medicaldevices #nebuliser #RNA #respiratory #inhalation

Huge congratulations to Elijah Nazarzadeh and the entire Nebu~Flow team for raising £4.7m in seed funding to optimize the next generation of inhaled drugs for patients with respiratory disorders.

The Conduit EIS Impact Fund are delighted to have backed this round alongside SCVC, Scottish Enterprise, Foresight Group, WAE, SIS Ventures , Ascension Life Fund.

We can't wait to see what's next! ✨🚀 

Read more: https://lnkd.in/eKjejhBC

#RNA #Nebluiser #inhalation

Amazon

COVID-19

United Kingdom Companies With More Than 10 Employees (Top 10K)

Medical Device Companies With Less Than $50M in Revenue (Top 10K)

Medical Device Companies With Less Than $500M in Revenue (Top 10K)

Scottish Enterprise Portfolio Companies

Nebu~Flow developing the next generation of nebulizers to enable the delivery of life-changing treatments.

Venture Round - Nebu~Flow

Seed Round - Nebu~Flow

Glasgow

Glasgow City

United Kingdom

Europe

Nebu~Flow

Nebu-Flow Raises Additional Funding

Nebu-Flow secures £4.7 million in funding

Glasgow medtech Nebu-Flow secures £4.7m in additional funding

Scottish inhaled drug delivery firm Nebu-Flow raises £4.7m

Nebu-Flow secures additional investment to accelerate next generation respiratory pharmaceuticals

Scottish pioneer aiming to revolutionise inhaled drug delivery takes major step

news_impact_assignment_basic

key_people

merger_acquisitions

network_dossier

public_peers

news_daily_refresh

news_processing_daily_refresh

news_impact_assignment_daily

news_processing_basic

legal

legal_dossier

bundesanzeiger

events_dossier

partnerships_market_presence_dossier

partnerships_market_presence

company_dossier

network

strategic_challenges

industry_trends

strategic_challenges_dossier

industry_trends_dossier

company_summary

events

network_mapping

transactions_dossier

swot_dossier

signals

financial_statements

crunchbase_trigger

crunchbase_profile

li_profile

financials_download_nd

private_financials

swot_analysis

financial_legal_advisories

company_structure

industry_analysis

financial_analysis

funding_rounds_analysis

regulatory_analysis

competition_analysis

news_impact_assignment_advanced

news_processing_advanced

news_advanced

purchaser_profile

network_onboarding

translate_crunchbase_fundingrounds

peers

customer_profile

news_basic

valuation

news impact assignment basic	general
public peers	general	Jul 18, 2024 6:36 AM	825a091b
news daily refresh	general
news processing daily refresh	general
news impact assignment daily	general
news processing basic	general	Jul 18, 2024 6:19 PM	67f0ccb4
company summary	general
signals	general
crunchbase trigger	general	Oct 30, 2024 1:02 PM	0058caf4
crunchbase profile	general	Oct 30, 2024 2:46 PM	1f798550
li profile	general	Jul 18, 2024 6:36 AM	3fbb1d56
translate crunchbase fundingrounds	general	Nov 6, 2024 3:12 PM	b2fb44f0
peers	general	Jul 18, 2024 6:36 AM	27f54725
news basic	general	Jul 18, 2024 6:36 AM	ce8235f8
bundesanzeiger	filings
financials download nd	financials
private financials	financials

COM:NEBUFLOW

Nebu-Flow